TREA

85691679 - UMOOZE

Follow

Information

  • Trademark
  • 85691679
  • Serial Number
    85691679
  • Registration Number
    4393791
  • Filing Date
    July 31, 2012
    12 years ago
  • Registration Date
    August 27, 2013
    11 years ago
  • Transaction Date
    April 16, 2024
    10 months ago
  • Status Date
    March 08, 2024
    11 months ago
  • Published for Opposition Date
    January 08, 2013
    12 years ago
  • Location Date
    March 10, 2019
    5 years ago
  • First Use Anywhere Date
    July 31, 2012
    12 years ago
  • First Use In Commerce Date
    January 08, 2013
    12 years ago
  • Status Code
    710
  • Current Location
    TMEG LAW OFFICE 106
    Employee Name
    SALEMI, DOMINICK
  • Attorney Docket Number
    GEN 250TM
    Attorney Name
    Hui Zhang
    Law Office Assigned Location Code
    L60
  • Owners
Information
Mark Drawing Code
5
Mark Identification
UMOOZE
Case File Statements
  • DM0000: The mark consists of the stylized letters "UMOOZE" with the two "O" 's overlapping.
  • GS0051: Adjuvants for medical purposes; Antiallergic medicines; Anti-cancer preparations; Medicinal herbal extracts for medical purposes; Pharmaceutical and medicinal preparations and substances for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, ocular disorders, or bone diseases, for use in dermatology, oncology, hematology and ophthalmology and for gastroenterological disorders or liver ailments; Pharmaceutical and medicinal preparations for the treatment of brain diseases or disorders and autoimmune diseases or disorders; Dietary and nutritional supplements for medical use; Dietary supplements for treating fatigue or liver support; Animal feed additive for use as a nutritional supplement for medical purposes; Dietary supplements for human consumption or for animals; Nutritional additives for medical purposes for use in foods for human consumption or for animals; Animal feed supplements; Dietary pet supplements in the form of pet treats; Fungi preparations for medical or veterinary use for treating disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, ocular disorders, brain diseases or disorders, autoimmune diseases or disorders, or bone diseases, for use in dermatology, oncology, hematology and ophthalmology and for gastroenterological disorders or liver ailments. Pharmaceutical preparations and substances for veterinary purposes for treating disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, ocular disorders, brain diseases or disorders, autoimmune diseases or disorders, or bone diseases, for use in dermatology, oncology, hematology and ophthalmology and for gastroenterological disorders or liver ailments; Chemical preparations for medicinal purposes for treating disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, ocular disorders, brain diseases or disorders, autoimmune diseases or disorders, or bone diseases, for use in dermatology, oncology, hematology and ophthalmology and for gastroenterological disorders or liver ailments; Cardiovascular pharmaceuticals; Cardiovascular treatment preparations; Pharmaceuticals preparations for the treatment of kidney diseases
  • CC0000: Color is not claimed as a feature of the mark.
Case File Event Statements
  • 5/21/2013 - 11 years ago
    9 - TEAS STATEMENT OF USE RECEIVED Type: EISU
  • 8/3/2012 - 12 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 8/9/2012 - 12 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 11/28/2012 - 12 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 11/28/2012 - 12 years ago
    4 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 12/19/2012 - 12 years ago
    5 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 1/8/2013 - 12 years ago
    6 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 1/8/2013 - 12 years ago
    7 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 3/5/2013 - 12 years ago
    8 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 7/1/2013 - 11 years ago
    13 - ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Type: CNPR
  • 8/27/2013 - 11 years ago
    17 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 8/27/2018 - 6 years ago
    18 - COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Type: REM1
  • 1/30/2019 - 6 years ago
    19 - TEAS SECTION 8 & 15 RECEIVED Type: E815
  • 5/21/2013 - 11 years ago
    11 - USE AMENDMENT FILED Type: IUAF
  • 6/19/2013 - 11 years ago
    12 - STATEMENT OF USE PROCESSING COMPLETE Type: SUPC
  • 6/19/2013 - 11 years ago
    10 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU
  • 7/19/2013 - 11 years ago
    14 - ASSIGNED TO LIE Type: ALIE
  • 7/19/2013 - 11 years ago
    15 - LAW OFFICE REGISTRATION REVIEW COMPLETED Type: REGV
  • 7/20/2013 - 11 years ago
    16 - NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Type: SUNA
  • 3/9/2019 - 5 years ago
    20 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE
  • 3/10/2019 - 5 years ago
    21 - REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Type: C15A
  • 8/27/2022 - 2 years ago
    23 - COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED Type: REM2
  • 3/8/2024 - 11 months ago
    24 - CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9 Type: CAEX
  • 3/10/2019 - 5 years ago
    22 - NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED Type: NA85